Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

1801881-17-3Apixaban Inhouse Impurity C

● Auf Lager

Katalog-Nr.::	VE008155
CAS-Nr.::	1801881-17-3
Summenformel::	C24H23N5O3
Molare Masse::	429.47 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 1801881-17-3

Parent drug

Apixaban

IUPAC-Name

7-Oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-1-phenyl-4, 5, 6, 7-tetrahydro-1H-pyrazolo[3, 4-c]pyridine-3-carboxamide

Synonyme

Apixaban Impurity 21/ Desmethoxy Apixaban

SMILES

O=C(C1=NN(C2=CC=CC=C2)C3=C1CCN(C4=CC=C(N5C(CCCC5)=O)C=C4)C3=O)N

Beschreibung

Apixaban Inhouse Impurity C (CAS No: 1801881-17-3) or 7-Oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-1-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide. it is used to prevent serious blood clots from forming due to a certain irregular heartbeat by Inhibition of factor Xa leads to decreased conversion of factor II to IIa, resulting in decreased thrombin generation.

References

Hurst, Katherine, et al. “Quick Reference Guide to Apixaban.” Vascular Health and Risk Management, vol. Volume 13, July 2017, pp. 263–267, 10.2147/vhrm.s121944.